CDB Aviation Completes Deliveries of Ten A320-200 Aircraft to Indonesia’s New Airline Super Air Jet
JAKARTA, Indonesia–(BUSINESS WIRE)–#AsiaPacific–CDB Aviation, a wholly owned Irish subsidiary of China Development Bank Financial Leasing…
News
Kingston Announces Hardware-Encrypted IronKey Keypad 200 USB Drive
Alphanumeric Keypad for PIN Access FIPS 140-3 Level 3 (Pending) Certified OS- and Device-Independent Multi-PIN…
OMNIVISION First to Bring High Dynamic Range 4K Video Conferencing to Laptop PCs
New OV08X is the industry’s only 9.2MP, 0.7-micron image sensor to provide 4K resolution for…
Kensu launches the first Data Observability Community Edition
Supporting the data community with the first free solution to monitor data pipelines and unleash…
Newly Released JumpCloud for MSPs™ Empowers Managed Service Providers to Modernize and Accelerate Growth
JumpCloud for MSPs™ Manages Identities, Access, and Devices at Scale; New Offering Delivers Easy, Frictionless…
Ultimovacs Announces Publication of Phase I Melanoma Trial Data in Journal of Translational Medicine
Comprehensive characterization of phase I UV1-checkpoint inhibitor combination trial Clinical responses seen in patients with…
Shape Therapeutics named one of Fierce Biotech’s “Fierce 15” Companies of 2022
SEATTLE, Sept. 12, 2022 (GLOBE NEWSWIRE) — Shape Therapeutics Inc. (ShapeTX), the RNA technology company…
Acasti Pharma to Participate at the H.C. Wainwright 24th Annual Global Investment Conference
LAVAL, Québec, Sept. 12, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
Opus Genetics Leadership to Present at 3rd Annual Gene Therapy for Ophthalmic Disorders Conference
RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2022 (GLOBE NEWSWIRE) — Opus Genetics, a patient-first gene…
Coherus BioSciences Management to Present at H.C. Wainwright 24th Annual Global Investment Conference
REDWOOD CITY, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today…
Agenus Initiates Botensilimab Phase 2 ACTIVATE Trials in Advanced MSS Colorectal Cancer and Advanced Melanoma
Phase 2 ACTIVATE trials to advance globally in metastatic patients who have progressed on available…
Agenus Makes Senior Regulatory and Clinical Appointments
Patricia Carlos named Chief Regulatory, Quality, and Safety Officer Todd Yancey, MD named Senior Global…
Pardes Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference
CARLSBAD, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage…
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
SOUTH SAN FRANCISCO, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN),…
Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million
SEATTLE, Sept. 12, 2022 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
Kiniksa Pharmaceuticals Announces Closing of Global License Agreement with Genentech for Vixarelimab
HAMILTON, Bermuda, Sept. 12, 2022 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a…
CytomX Therapeutics Announces Phase 1 Data Update for anti-CTLA-4 Probody® Therapeutic BMS-986249
– Presentation at ESMO 2022 by Collaborator, Bristol Myers Squibb –– BMS-986249 Phase 2 study…
Enlivex Announces New Preclinical Data in Murine Mesothelioma Model Showing a Substantial Survival Benefit with Allocetra as Monotherapy and in Combination with Cisplatin at the ESMO Congress 2022
Currently used cisplatin-based combination treatments have limited efficacy against mesothelioma, which is one of the…
Revolo Biotherapeutics Completes Enrollment in Phase 2 Trial of ‘1104 in Eosinophilic Esophagitis
Topline data anticipated around year-end 2022 NEW ORLEANS and LONDON, Sept. 12, 2022 (GLOBE NEWSWIRE)…
AmMax Bio Announces Presentation of Phase 2 PK/PD Data of ABM-05X for the Treatment of Tenosynovial Giant Cell Tumor (TGCT) at ESMO Congress 2022
Unique, intra-articular administration of AMB-05X yielded sustained, high synovial concentrations with low systemic exposures and…